Botox or Botox With Esophageal Dilation in Patients With Achalasia
Status:
Enrolling by invitation
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Achalasia is a rare esophageal motility disorder. Treatment of achalasia is aimed toward
palliation of symptoms. These include botox injections to the lower esophageal sphincter
(LES), pneumatic dilation, surgical myotomy, and per-oral endoscopic myotomy (POEM). Botox
injections are frequently used for patients that have significant comorbidities. The primary
aim of this study is to assess symptomatic response of patient with achalasia to esophageal
dilation and botox injection to the LES compared to standard therapy of only botox injection.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Medical Center
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A onabotulinumtoxinA